Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 3
2015 2
2016 3
2018 3
2019 5
2020 6
2021 10
2022 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cecile vivier (1 results)?
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Jacot W, Lusque A, Vicier C, Mailliez A, de La Motte Rouge T, Cabel L, Levy C, Patsouris A, Desmoulins I, Uwer L, Thery JC, Robain M, Caron O, Tredan O, Filleron T, Frenel JS, Delaloge S. Jacot W, et al. Among authors: vicier c. Br J Cancer. 2022 Nov;127(11):1963-1973. doi: 10.1038/s41416-022-02003-1. Epub 2022 Oct 7. Br J Cancer. 2022. PMID: 36207609 Free PMC article. Clinical Trial.
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Billon E, Gravis G, Guille A, Carbuccia N, Adelaide J, Garnier S, Finetti P, Denicolaï E, Sfumato P, Brunelle S, Thomassin-Piana J, Pignot G, Walz J, Chabannon C, Pakradouni J, Sabatier R, Vicier C, Popovici C, Mamessier E, Gonçalves A, Birnbaum D, Chaffanet M, Bertucci F. Billon E, et al. Among authors: vicier c. Cancers (Basel). 2022 May 3;14(9):2275. doi: 10.3390/cancers14092275. Cancers (Basel). 2022. PMID: 35565404 Free PMC article.
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
Guillaume Z, Colomba E, Thouvenin J, Saldana C, Campedel L, Dumont C, Laguerre B, Maillet D, Vicier C, Rolland F, Borchiellini D, Barthelemy P, Albiges L, Auclin E, Roulleaux Dugage M, Oudard S, Thibault C. Guillaume Z, et al. Among authors: vicier c. Cancers (Basel). 2022 Mar 25;14(7):1678. doi: 10.3390/cancers14071678. Cancers (Basel). 2022. PMID: 35406448 Free PMC article.
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Sabatier R, Vicier C, Garnier S, Guille A, Carbuccia N, Isambert N, Dalenc F, Robert M, Levy C, Pakradouni J, Adelaïde J, Chaffanet M, Sfumato P, Mamessier E, Bertucci F, Goncalves A. Sabatier R, et al. Among authors: vicier c. Mol Oncol. 2022 May;16(10):2057-2070. doi: 10.1002/1878-0261.13188. Epub 2022 Mar 30. Mol Oncol. 2022. PMID: 35122700 Free PMC article. Clinical Trial.
Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.
Patsouris A, Diop K, Tredan O, Nenciu D, Gonçalves A, Arnedos M, Sablin MP, Jézéquel P, Jimenez M, Droin N, Bièche I, Callens C, Loehr A, Vicier C, Guerin C, Filleron T, André F. Patsouris A, et al. Among authors: vicier c. Eur J Cancer. 2021 Dec;159:283-295. doi: 10.1016/j.ejca.2021.09.028. Epub 2021 Nov 25. Eur J Cancer. 2021. PMID: 34837859 Free article. Clinical Trial.
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients.
Vicier C, Sfumato P, Isambert N, Dalenc F, Robert M, Levy C, Rezai K, Provansal M, Adélaïde J, Garnier S, Guille A, Carbuccia N, Popovici C, Charafe-Jauffret E, Chaffanet M, Birnbaum D, Pakradouni J, Bertucci F, Boher JM, Sabatier R, Gonçalves A. Vicier C, et al. Eur J Cancer. 2021 Dec;159:205-214. doi: 10.1016/j.ejca.2021.09.040. Epub 2021 Nov 12. Eur J Cancer. 2021. PMID: 34781168 Clinical Trial.
Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
Rony M, Ratone JP, Walz J, Pignot G, Caillol F, Pesenti C, Guerin M, Dermeche S, Brunelle S, Salem N, Vicier C, Rybikowski S, Maubon T, Fakhfakh S, Tejeda M, Giovannini M, Gravis G. Rony M, et al. Among authors: vicier c. Front Oncol. 2021 Jun 14;11:710477. doi: 10.3389/fonc.2021.710477. eCollection 2021. Front Oncol. 2021. PMID: 34195098 Free PMC article.
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Bertucci F, Gonçalves A, Guille A, Adelaïde J, Garnier S, Carbuccia N, Billon E, Finetti P, Sfumato P, Monneur A, Pécheux C, Khran M, Brunelle S, Mescam L, Thomassin-Piana J, Poizat F, Charafe-Jauffret E, Turrini O, Lambaudie E, Provansal M, Extra JM, Madroszyk A, Gilabert M, Sabatier R, Vicier C, Mamessier E, Chabannon C, Pakradouni J, Viens P, André F, Gravis G, Popovici C, Birnbaum D, Chaffanet M. Bertucci F, et al. Among authors: vicier c. Genome Med. 2021 May 18;13(1):87. doi: 10.1186/s13073-021-00897-9. Genome Med. 2021. PMID: 34006291 Free PMC article. Clinical Trial.
37 results